Activation of nuclear factor erythroid 2-related factor 2/xCT/GPX4 signaling pathway attenuates CMs ferroptosis in doxorubicin-induced cardiomyopathy and myocardial I/R injury by inhibiting oxidative stress (41, 42). Here, SLC7A11 is linked to cardiomyopathy.